ADVANCED MALIGNANT NEOPLASM
Clinical trials for ADVANCED MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat leukemia: first patients test novel drug
Disease control Recruiting nowThis is the first time a new drug called ziftomenib is being tested in people. The study aims to find a safe and effective dose for adults with advanced acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) that has returned or not responded to other treatments. It w…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC